TUESDAY, June 13, 2023 (HealthDay News) — Imagine struggling to remember your loved ones, the places you’ve been or even your own name. The haunting reality of Alzheimer’s disease and dementia is a terrifying prospect for many individuals and their families. Alzheimer’s disease, a type of dementia, gradually erodes memory,Continue Reading
FRIDAY, June 2, 2023 (HealthDay News) — Medicare will soon cover a new class of Alzheimer’s drugs if they receive full approval from the U.S. Food and Drug Administration, with some key limits. Along with being full approved, drug makers will also have to gather and keep data in aContinue Reading
THURSDAY, May 25, 2023 (HealthDay News) — Prediabetes often precedes type 2 diabetes, the form of the disease most closely tied to obesity. A new study suggests that the timing of this transition may set the stage for dementia in later years. Prediabetes refers to blood sugar or glucose levelsContinue Reading
THURSDAY, May 25, 2023 (HealthDay News) – People with a genetic predisposition to Alzheimer’s disease may have an increased risk of epilepsy, a new study says. And folks with a certain type of epilepsy may have higher odds of developing Alzheimer’s disease. Having Alzheimer’s was linked to a 5.3% increasedContinue Reading
FRIDAY, May 19, 2023 (HealthDay News) — A new brain bank is accepting future donations from living athletes, in an effort to perform long-term research into the effects of sports-related concussion. The National Sports Brain Bank (NSBB) at the University of Pittsburgh will track the health of living participants onContinue Reading
MONDAY, May 15, 2023 — Researchers have discovered a genetic mutation that should actively protect people from Alzheimer’s, thanks to a man belonging to a Colombian family known to be susceptible to the degenerative brain disease. Based on his family’s genetics, this unnamed patient should have started showing signs ofContinue Reading
FRIDAY, May 12, 2023 (HealthDay News) — Mother’s Day can require some creative thinking when your mom has dementia. “Mother’s Day is a time to honor the special mother figures in your life, and if your loved one lives with dementia, it can continue to be special with a fewContinue Reading
THURSDAY, May 11, 2023 (HealthDay News) — A medication to treat agitation in Alzheimer’s patients now has approval from the U.S. Food and Drug Administration. The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti is the first FDA-approvedContinue Reading
THURSDAY, May 11, 2023 (HealthDay News) — Poor sleep brought on by sleep apnea may ultimately undermine the brain health of older men and women, new research suggests. The concern stems from a new brain scan investigation that involved 140 sleep apnea patients. “Sleep apnea is a medical condition inContinue Reading
WEDNESDAY, May 10, 2023 (HealthDay News) — Researchers have isolated for the first time a free-floating form of amyloid beta that appears to be a key driver of Alzheimer’s disease. Further, they argue that a newly approved Alzheimer’s drug — lecanemab (Leqembi) — directly targets these small, complex chains ofContinue Reading
TUESDAY, May 9, 2023 (HealthDay News) — People who repeatedly suffer traumatic brain injuries (TBI) may be more apt to develop Alzheimer’s disease, new research shows. TBI can result from direct hits to the head or from indirect sources such as shockwaves from battlefield explosions. The brains of otherwise healthyContinue Reading
MONDAY, May 8, 2023 (HealthDay News) — In a world increasingly consumed by social media, much has been made of the amount of time younger generations spend online every day — and the harms that habit can bring. But now a new study of older adults suggests that regular internetContinue Reading
FRIDAY, May 5, 2023 (HealthDay News) — Getting good sleep is an important part of wellness for many reasons, but new research suggests deep sleep may even guard against memory loss linked to Alzheimer’s. While disrupted sleep has been linked with accumulating beta-amyloid plaques in the brain faster, scientists foundContinue Reading
WEDNESDAY, May 3, 2023 (HealthDay News) — Another experimental drug meant for Alzheimer’s disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June. Known as donanemab, the medication clears amyloid plaque from the brain. InContinue Reading